<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Interleukin-1 beta (IL-1 beta) is an inflammatory cytokine </plain></SENT>
<SENT sid="1" pm="."><plain>We measured its production in 21 Behçet's disease patients, 4 healthy controls, and 4 sarcoidosis patients, by enzyme-linked immunosorbent assay (ELISA) after stimulation with <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> from peripheral blood monocytes </plain></SENT>
<SENT sid="2" pm="."><plain>IL-1 beta production of the posterior segment type was significantly greater (p &lt; 0.001) than in healthy controls, <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> patients, and anterior segment type </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> posterior segment type cases, IL-1 beta production in the active period was greater than in the remission period </plain></SENT>
<SENT sid="4" pm="."><plain>IL-1 beta production is considered to be related to posterior segment type attacks of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
</text></document>